CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


C3+ Holter MonitorWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1505 MinnRAP Peer Support Program Wiki 1.00

Correlated MeSH Terms (8)


Name (Synonyms) Correlation
D015775 Fractures, Stress NIH 1.00
D000068376 Compassion Fatigue NIH 0.71
D000067073 Psychological Trauma NIH 0.58
D040921 Stress Disorders, Traumatic NIH 0.22
D013315 Stress, Psychological NIH 0.21
D013313 Stress Disorders, Post-Traumatic NIH 0.20
D004194 Disease NIH 0.18
D001008 Anxiety Disorders NIH 0.17

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 The ACOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart by Continuous ECG Monitoring

The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if continuous ECG monitoring can be used to understand the contribution of COVID-19 infection in the acute phase to the development of cardiac arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the investigators aim to examine if continuous ECG monitoring - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection.

NCT04395664 COVID-19 Device: C3+ Holter Monitor

Primary Outcomes

Measure: In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis

Time: 4 months

Measure: Incident intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis

Time: 4 months

Secondary Outcomes

Measure: Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis

Time: 4 months

Measure: Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis

Time: 4 months

Measure: Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis

Time: 4 months


No related HPO nodes (Using clinical trials)